update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
Published 8 months ago • 67 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
3:44
phase ii study update of navtemadlin in patients with myelofibrosis r/r to ruxolitinib
-
1:44
an update on imetelstat in r/r myelofibrosis
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
1:52
an update on the use of navtemadlin in myelofibrosis
-
3:40
current unmet needs in pv & et
-
1:19
what's on the horizon for the treatment of mpns?
-
1:39
new horizons in pnh
-
10:01
thrombocytopaenia (low platelets) overview - platelet physiology, classification, pathophysiology
-
4:49
myelofibrosis - causes, symptoms, diagnosis, treatment, pathology
-
9:04
tavr or tavi 1: echo evaluation
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
1:45
mechanism of action of bitopertin to treat patients with epp
-
1:25
phase ii trial of eprenetapopt plus azacitidine: long-term follow up
-
2:50
beacon trial results: safety & efficacy of bitopertin in adults with epp
-
29:09
update from industry
-
4:55
new, novel navitor™ tavi valve with active paravalvular leak-sealing technology - europcr 2021
-
0:14
post-dilation of evolut r valve with significant improvement in valve expansion
-
16:16
precigen
-
2:29
outcomes of repeat tavr with balloon-expandable valves - europcr 2023
-
2:19
cepheid robal cartridge ru subtitles
-
40:32
tavi for ar - addressing an unmet need with the jenavalve trilogy heart valve system - europcr 2022